| 2025-02-18 00:59:00 |
Dupixent® (dupilumab) Sbla Accepted For Fda Priority Review For The Targeted Treatment Of Bullous Pemphigoid (bp)
If approved, dupixent would be the first and only targeted medicine to treat bp in the u.s.; fda decision expected by june 20, 2025 |
| 2024-11-18 08:15:00 |
Corteva Announces Intent To Partner With Bp To Develop Low Carbon Intensity Bio-feedstock For Aviation Fuel Production
Indianapolis , nov. 18, 2024 /prnewswire/ -- corteva inc. (nyse: ctva) announced today a collaboration with bp (nyse: bp, lse: bp.l) on the companies’ shared intent to form a crop-based biofuel feedstock joint venture (jv). the jv envisaged by corteva and bp would produce and deliver crop-based biofuel feedstocks to help meet the anticipated growth in demand for ’sustainable aviation fuel’ (saf). |
| 2024-10-07 07:58:00 |
Bp Introduces Earnify™app: Enhancing The Fuel And Convenience Store Experience
Earnify™ aims to simplify and reward fueling and shopping by integrating an intuitive loyalty program and a streamlined user experience. exclusive introductory offer includes double points for the first 90 days and 250 welcome points after registration. |
| 2024-10-02 13:35:00 |
Wellvii™ And B-secur Announce Strategic Partnership To Integrate Single-lead Ecg Into Bp Go, Creating The Most Compact At-home Bp/ecg Combination Device
Palm beach gardens, fla.--(business wire)--wellvii inc., creators of the fda-cleared blood pressure from the finger that replaces the traditional nibp arm cuff, today announced a strategic partnership with b-secur, a leader in advanced biosensing technology. this collaboration brings b-secur’s cutting-edge single-lead ecg into wellvii’s bp go, revolutionizing the at-home blood pressure and heart health monitoring market. the bp go rhythm bp/ecg device will offer more convenience, comfort, and p. |
| 2024-09-11 00:59:00 |
Dupixent® (dupilumab) Is The First And Only Biologic To Achieve Significant Improvements In Disease Remission And Symptoms In Bullous Pemphigoid (bp) Positive Pivotal Trial
Trial met the primary and all key secondary endpoints in adults with moderate-to-severe disease; five times more patients achieved sustained disease remission with dupixent than placebo |
| 2024-09-09 06:59:00 |
UGFsYW50aXIgQW5kIEJw IEFncmVlIFRvIDUteWVh ciBTdHJhdGVnaWMgUmVs YXRpb25zaGlwIFdpdGgg TmV3IEFpIENhcGFiaWxp dGllcw==
RGVudmVyLS0oYnVzaW5l c3Mgd2lyZSktLXBhbGFu dGlyIHRlY2hub2xvZ2ll cyBpbmMuIChueXNlOnBs dHIpIGFuZCBicCAobnlz ZTpicCkgaGF2ZSBhbm5v dW5jZWQgYW4gZW50ZXJw cmlzZSBhZ3JlZW1lbnQg dGhhdCB3aWxsIGV4dGVu ZCB0aGVpciBzdHJhdGVn aWMgcmVsYXRpb25zaGlw IGFuZCBpbnRyb2R1Y2Ug bmV3IGFydGlmaWNpYWwg aW50ZWxsaWdlbmNlIGNh cGFiaWxpdGllcyB3aXRo IHBhbGFudGly4oCZcyBh aXAgc29mdHdhcmUuIHRo ZSBuZXcgY29udHJhY3Qg d2lsbCBidWlsZCBvbiBh IGRlY2FkZSBvZiBkZWVw IGNvbGxhYm9yYXRpb24g dGhhdCBoYXMgY3JlYXRl ZCBhIGZpcm0gZm91bmRh dGlvbiBmb3IgYnDigJlz IG9pbCBhbmQgZ2FzIHBy b2R1Y3Rpb24gb3BlcmF0 aW9ucywgdXNpbmcgcGFs YW50aXLigJlzIGluZHVz dHJ5LWxlYWRpbmcgc29m dHdhcmUuIHNpbmNlIDIw MTQsIHBhbGFudGlyIHNv ZnR3YXJlIGhhcyBiZWVu IGRlcGxveWVkIHdpZGVs eSBieSBicCB0by4=
|
| 2024-08-29 07:15:00 |
VS5zLiBMaWZlIENvYWNo IEluc2lnaHRzIFJlcG9y dCAyMDI0OiBBICQyLjc1 KyBCbiBNYXJrZXQgQnkg MjAyOSBEb21pbmF0ZWQg QnkgQmVuY2htYXJrLCBC ZXR0ZXJ1cCwgQnAsIEVu ZGxlc3MgUG9zc2liaWxp dGllcywgTm9vbWlpLCBQ YWNpZmljIExpZmUgQ29h Y2gsIFN1bm55LCBUaHJp dmV3b3JrcyBBbmQgUm9i YmlucyBSZXNlYXJjaA==
RHVibGluLCBhdWcuIDI5 LCAyMDI0IChnbG9iZSBu ZXdzd2lyZSkgLS0gdGhl IFwidS5zLiBsaWZlIGNv YWNoIG1hcmtldCAtIGZv Y3VzZWQgaW5zaWdodHMg MjAyNC0yMDI5XCIgcmVw b3J0IGhhcyBiZWVuIGFk ZGVkIHRvIHJlc2VhcmNo YW5kbWFya2V0cy5jb23i gJlzIG9mZmVyaW5nLiB0 aGUgdS5zLiBsaWZlIGNv YWNoIG1hcmtldCBpcyBl eHBlY3RlZCB0byByZWFj aCBhIHZhbHVlIG9mICQy Ljc2IGJpbGxpb24gYnkg MjAyOSBmcm9tICQyLjA3 IGJpbGxpb24gaW4gMjAy MywgZ3Jvd2luZyBhdCBh IGNhZ3Igb2YgNC45NSU=
|
| 2024-08-20 15:44:00 |
QXVkdWJvbiBDaG9zZW4g Rm9yIEZwdSBFbmdpbmVl cmluZyBPbiBCcCBLYXNr aWRhIFByb2plY3QgSW4g VGhlIEd1bGYgT2YgTWV4 aWNv
SG91c3Rvbi0tKGJ1c2lu ZXNzIHdpcmUpLS0gI2Zw dS0tYnAgaGFzIHNlbGVj dGVkIGF1ZHVib24gZm9y IGVuZ2luZWVyaW5nIHRo ZSB0b3BzaWRlIG9mIGl0 cyBrYXNraWRhIGZwdSBp biB0aGUgZ3VsZiBvZiBt ZXhpY28u
|
| 2024-06-24 10:00:00 |
QXJjYWRpcyBDb21wbGV0 ZXMgQ2hhcmdlciBJbnN0 YWxsYXRpb24gRm9yIEJw IFB1bHNl4oCZcyBGaXJz dCBIaWdoLXNwZWVkIEV2 IEdpZ2FodWLihKIgSW4g VGhlIFVz
QXJjYWRpcyBoYXMgZGVs aXZlcmVkIG1vcmUgdGhh biA3LDAwMCBldiBjaGFy Z2luZyBzdGF0aW9ucyBh cm91bmQgdGhlIHdvcmxk IGhvdXN0b24gLCBqdW5l IDI0LCAyMDI0IC9wcm5l d3N3aXJlLyAtLcKgYXJj YWRpcywgYSBsZWFkaW5n IGdsb2JhbCBkZXNpZ24g YW5kIGNvbnN1bHRhbmN5 IG9yZ2FuaXphdGlvbiBm b3IgbmF0dXJhbCBhbmQg YnVpbHQgYXNzZXRzLCB0 b2RheSBhbm5vdW5jZWQg dGhlIGNvbXBsZXRpb24g b2YgYnDigJlzIChueXNl OiBicCkgbGF0ZXN0IGhp Z2gtc3BlZWQgZXYgY2hh cmdpbmcgc2l0ZSBhdCB0 aGUgY29tcGFueeKAmXMg bm9ydGggYW1lcmljYSBo ZWFkcXVhcnRlcnMgaW4g aG91c3RvbiwgdGV4YXMu IHRoZSBuZXcgYnAgcHVs c2Ugc3RhdGlvbiBpcyB0 aGUgZmlyc3QgYnAgcHVs c2UgYnJhbmRlZCBnaWdh aHVi4oSiIGluIHRoZSB1 cyBmb3IgdGhlaXIgZXYg Y2hhcmdpbmcgYnVzaW5l c3Mu
|
| 2024-06-13 08:32:00 |
QXJjaGFlYSBFbmVyZ3kg QW5kIFJlcHVibGljIFNl cnZpY2VzIENlbGVicmF0 ZSBGaXJzdCBSbmcgUGxh bnQgSW4gTGFuZG1hcmsg UGFydG5lcnNoaXA=
TGlnaHRuaW5nIHJlbmV3 YWJsZXMgam9pbnQgdmVu dHVyZSB0YXJnZXRzIGJy aW5naW5nIGFwcHJveGlt YXRlbHkgNDAgbGFuZGZp bGwgZ2FzLXRvLXJlbmV3 YWJsZSBuYXR1cmFsIGdh cyBwbGFudHMgb25saW5l IGluIGNvbWluZyB5ZWFy cy4gZm9ydCB3YXluZSBw bGFudCBpcyB0aGUgbGFy Z2VzdCBhcmNoYWVhIG1v ZHVsYXIgZGVzaWduIGlu IGluZGlhbmEsIHByb2Nl c3NpbmcgdXAgdG8gNiw0 MDAgc3RhbmRhcmQgY3Vi aWMgZmVldCBvZiBsYW5k ZmlsbCBnYXMgcGVyIG1p bnV0ZSAoc2NmbSksIGVu b3VnaCBlbmVyZ3kgdG8g aGVhdCBtb3JlIHRoYW4g MjUsMDAwIGhvbWVzLCBh Y2NvcmRpbmcgdG8gdGhl IGVwYSBsYW5kZmlsbCBn YXMgZW5lcmd5IGJlbmVm aXRzIGNhbGN1bGF0b3Iu
|
| 2024-05-30 15:02:00 |
Q2FzdHJvbMKuIFVudmVp bHMgTmV3IEJyYW5kaW5n IEFuZCBCZXN0LWluLWNs YXNzIFByb2R1Y3QgQ2xh aW1zIEFjcm9zcyBJdHMg RnVsbCBTeW50aGV0aWMg UmFuZ2U=
V2F5bmUsIG4uai4tLShi dXNpbmVzcyB3aXJlKS0t ICNjYXN0cm9sLS1jYXN0 cm9swq4gdW52ZWlscyBu ZXcgYnJhbmRpbmcgZm9y IGl0cyBsaW5lIG9mIHN5 bnRoZXRpYyBvaWxzLCBh cyB3ZWxsIGFzIG11bHRp cGxlIG5ldywgaW5kdXN0 cnktbGVhZGluZyBjbGFp bXMgc3Vycm91bmRpbmcg cGVyZm9ybWFuY2UgYW5k IHByb3RlY3Rpb24u
|
| 2024-05-21 06:00:00 |
RXYgQ29ubmVjdCBBbmQg QnAgUHVsc2UgQ29sbGFi b3JhdGUgVG8gRGVsaXZl ciBDb21wcmVoZW5zaXZl IEZsZWV0IE1hbmFnZW1l bnQgU29sdXRpb24=
RWwgc2VndW5kbywgY2Fs aWYuLS0oYnVzaW5lc3Mg d2lyZSktLXdpdGggNS43 IG1pbGxpb24gZWxlY3Ry aWMgdmVoaWNsZXMgKGV2 cykgYW50aWNpcGF0ZWQg dG8gYmUgdXNlZCBpbiBm bGVldCBhcHBsaWNhdGlv bnMgYnkgMjAyNSwgZXYg Y29ubmVjdCwgYSBsZWFk aW5nIGV2IGNoYXJnaW5n IGJ1c2luZXNzIHBsYXRm b3JtLCBhbmQgYnAgcHVs c2UsIGEgZ2xvYmFsIGxl YWRlciBpbiBjaGFyZ2lu ZyBpbmZyYXN0cnVjdHVy ZSBmb3IgZmxlZXRzIGFu ZCBwdWJsaWMgY2hhcmdp bmcsIHRvZGF5IGFubm91 bmNlZCBhIGNvbGxhYm9y YXRpb24gdG8gYnJpbmcg a2V5IGNhcGFiaWxpdGll cyBvZiBvbWVnYSwgYnAg cHVsc2XigJlzIGV2IGNo YXJnZSBtYW5hZ2VtZW50 IHNvZnR3YXJlLCB0byB0 aGUgZXYgY29ubmVjdCBw bGF0Zm9ybS4gdGFpbG9y ZWQgdG8gdGhlIGRpdmVy c2UgY2hhcmdpbmcgcmVx dWlyZW1lbnRzIGFuZCBk dXR5IGN5Y2xlcyBvZiBl diBmbGVldHMsIG9tZWdh IGRlbGl2Lg==
|
| 2024-05-20 07:58:00 |
QW1vY28gVWx0aW1hdGXC riBXaXRoIEludmlnb3Jh dGXCriBDYW4gVGFrZSBZ b3UgVXAgVG8gMzAwIE1p bGVzIEZhcnRoZXIgUGVy IFllYXLCuQ==
QW1vY28gdWx0aW1hdGXC riB3aXRoIGludmlnb3Jh dGXCriBjYW4gdGFrZSB5 b3UgdXAgdG8gMzAwIG1p bGVzIGZhcnRoZXIgeWVh cmx5LCBjb21wYXJlZCB0 byByZWd1bGFyIGZ1ZWwg aW4gdG9wLXNlbGxpbmcg c2VkYW5zIGFuZCBjYXLC oHN1dnMuIGJw4oCZcyBc IjMwMCBtaWxlcyBmYXJ0 aGVyXCIgY2FtcGFpZ24g aXMgYW4gdW5tYXRjaGVk IGNsYWltIHRoYXQgZW5h YmxlcyBkcml2ZXJzIHRv IGNvdmVyIG1vcmUgZGlz dGFuY2UgYmV0d2VlbiBm aWxsLXVwcyB3aXRoIGNv bmZpZGVuY2Uu
|
| 2024-04-30 11:00:00 |
QnDigJlzIEFyY2hhZWEg RW5lcmd5IEJyaW5ncyBP bmxpbmUgSXRzIExhcmdl c3QgTW9kdWxhciBSbmcg UGxhbnQgVG8gRGF0ZSBJ biBLYW5zYXM=
VGhlIHBsYW50IGNhbiBj b252ZXJ0IDksNjAwIHN0 YW5kYXJkIGN1YmljIGZl ZXQgb2YgbGFuZGZpbGwg Z2FzIHBlciBtaW51dGUg aW50byBsb3dlci1jYXJi b24gcmVuZXdhYmxlIG5h dHVyYWwgZ2FzIChybmcp LiBwbGFudCBpcyBleHBl Y3RlZCB0byBwcm9kdWNl IGVub3VnaCByZW5ld2Fi bGUgbmF0dXJhbCBnYXMg dG8gaGVhdCB1cCB0byAz OCwwMDAgaG9tZXMgYW5u dWFsbHksIGFjY29yZGlu ZyB0byB0aGUgZXBhIGxh bmRmaWxsIGdhcyBlbmVy Z3kgYmVuZWZpdHMgY2Fs Y3VsYXRvci4=
|
| 2024-04-11 01:00:00 |
SWNlYnJlYWtlciBCb3Ru aWNhIFN1bW1lciBDaGFy dGVyIENvbnRyYWN0IFdp dGggQnAgRm9yIDIwMjQ=
VGhlIHN1YnNpZGlhcnkg Y29tcGFueSBvZiBhcyB0 YWxsaW5uYSBzYWRhbSwg b8OcIHRzIHNoaXBwaW5n LCBzaWduZWQgYW4gYWdy ZWVtZW50IHdpdGggYnAg ZXhwbG9yYXRpb24gb3Bl cmF0aW5nIGNvbXBhbnkg bHRkIChoZXJlaW5hZnRl cjogYnApIGZvciBjaGFy dGVyaW5nIG11bHRpZnVu Y3Rpb25hbCBpY2VicmVh a2VyIGJvdG5pY2EgZnJv bSBtYXkgdG8ganVseSAy MDI0IHdpdGggdGhlIG9w dGlvbiB0byBleHRlbmQg dGhlIHRlcm0gdW50aWwg NSBhdWd1c3QsIHRoZSBj aGFydGVyIHBlcmlvZCBp biB0b3RhbCBpcyB1cCB0 byAxMiB3ZWVrcy4gYnAg aXMgYSBtdWx0aW5hdGlv bmFsIGVuZXJneSBjb21w YW55IGJhc2VkIGluIHVr LiBhY2NvcmRpbmcgdG8g dGhlIHNjb3BlIG9mIHNl cnZpY2UsIGJvdG5pY2Eg d2lsbCBiZSBjaGFydGVy ZWQgYXMgYSBzZXJ2aWNl IG9wZXJhdGlvbiB2ZXNz ZWwgdG8gc3VwcG9ydCB3 b3JrIHNjb3BlcyBhdCBi cOKAmXMgbXVuZ28gbm9y bWFsbHkgdW5hdHRlbmRl ZCBpbnN0YWxsYXRpb24s IGxvY2F0ZWQgaW4gdGhl IG5vcnRoIHNlYSB1ayBz ZWN0b3Iu
|
